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CORRESPONDENCE
Facts and Not Fiction: The Small Aneurysm
Trials do Not Justify Early Surgical
Intervention
Debate is the cornerstone of progress and we welcome
critical appraisal of our contribution to evidence-based
medicine, the UK Small Aneurysm Trial.1–4 Professor
Branchereau attempts to use the evidence we provided
to make a case for early intervention for ‘good risk
patients’ with all abdominal aortic aneurysms (AAA)
greater than 5 cm in diameter.5
Such a strategy is not supported by evidence. In
analyses of the UK Small Aneurysm Trial data, by
subgroups of aneurysm size, age and gender, there
were no clear-cut differences in results.1,4 Professor
Branchereau selectively cites results in particular
subgroups, without reference either to their impreci-
sion or to whether they were convincingly different
from other subgroups. Other support from Professor
Branchereaus’s argument is based largely on
misconception.
First, the UK Small Aneurysm Trial was designed
and powered to show the superiority of early surgery
after 5-years of follow up. Randomisation of 1000
patients should have given us an 80% chance of
showing a true difference in 5-year survival (29%
mortality for early surgery and 38% mortality for
surveillance patients).1
Second, the late survival results reported in 20024
included events for patients no longer followed up by
trial protocol and hence data must be interpreted with
due caution. Further, with respect to cause of death, at
all time points the knowledge that a patient has AAA,
is more likely to lead to a diagnosis of ruptured AAA
in cases of sudden death.
Third, Professor Branchereau has misquoted
important results. The 5.8% surgical mortality rate
reported was for all surgery (emergency and elective),
not just elective surgery. The rupture rate for patients
within trial protocol was 1% per annum. The 1167
patients followed up for rupture outside the trial
included a sizeable cohort ðn ¼ 100Þ with AAA
diameter .5.5 cm, where the crude rupture rate was
28% per annum. Nevertheless the overall rupture rate
was only 2.2% per annum.3
The most persuasive support for the UK Small
Aneurysm Trial results comes from the similar
Aneurysm Detection and Management trial, where
even with an operative mortality half of that in the UK
trial, early surgery did not improve 5-year survival.6
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